1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Finland >
  5. Targovax AS Acquires Oncos Therapeutics Oy

M&A Deal Summary

Targovax AS Acquires Oncos Therapeutics Oy

On June 18, 2015, Targovax AS acquired life science company Oncos Therapeutics Oy

Acquisition Highlights
  • This is Targovax AS’s 1st transaction in the Life Science sector.
  • This is Targovax AS’s 1st transaction in Finland.

M&A Deal Summary
Date 2015-06-18
Target Oncos Therapeutics Oy
Sector Life Science
Buyer(s) Targovax AS
Deal Type Add-on Acquisition
Advisor(s) Guggenheim Securities (Financial)

Target

Oncos Therapeutics Oy

Helsinki, Finland
Oncos Therapeutics Oy is a biotechnology company focused on the development and commercialization of targeted cancer immunotherapy.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Targovax AS

Lysaker, Norway
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Targovax AS is a biotechnology company, dedicated to the design and development of immunotherapy vaccines for patients with RAS-mutated cancers.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Finland M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal